Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) (An ALCHEMIST Treatment Trial) |
---|---|
Disease/Condition | Lung Cancer,Medical and Hematologic Oncology,Lung Diseases,Carcinoma,Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Haiying Cheng, MD |
Contact Name | Remy Lambert |
Contact Email | rlambert@montefiore.org |
Protocol Number | 2016-7052 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Lung Cancer - NSCLC removed by surgery |
Adult, Pediatric, Both | Adult |